The Correlation between PSCA Expression and Neuroendocrine Differentiation in Prostate Cancer

Area of Science:

• Oncology
• Molecular Biology
• Pathology

Background:

• Prostate stem cell antigen (PSCA) is overexpressed in prostate cancer and linked to androgen independence.
• Castration-resistant prostate cancer (CRPC) and neuroendocrine prostate cancer (NEPC) represent advanced disease stages.
• Neuroendocrine prostate cancer (NEPC) is characterized by neuroendocrine markers like enolase 2 (NSE).

Purpose of the Study:

• To investigate the expression of PSCA and NSE in prostate cancer.
• To determine the relationship between PSCA and NSE expression.
• To correlate PSCA and NSE expression with clinicopathological parameters and patient prognosis.

Main Methods:

• Immunohistochemistry was used to analyze PSCA and NSE protein expression.
• Prostate cancer tissue specimens from 118 patients were examined.
• Statistical analysis was performed to assess correlations between marker expression and clinicopathological data.

Main Results:

• PSCA and NSE expression correlated significantly with pathological tumor stage, Gleason score, and metastasis.
• A positive association was found between PSCA and NSE expression.
• Prostate-specific antigen (PSA) showed a negative correlation with both PSCA and NSE expression.
• High PSCA and NSE expression were associated with a poor prognosis.

Conclusions:

• PSCA and NSE expression are linked to aggressive features and poor outcomes in prostate cancer.
• PSCA may play a crucial role in the development and progression of neuroendocrine prostate cancer (NEPC).
• The inverse relationship between PSA and PSCA/NSE warrants further investigation.